CFTR
CFTR (cystic fibrosis transmembrane conductance regulator) is an ABC transporter-class ion channel that conducts chloride[3] and thiocyanate[4] ions across epithelial cell membranes.
Products for CFTR
- Cat.No. Product Name Information
-
GC31665
(R)-BPO-27
(R)-BPO-27, the R enantiomer of BPO-27, is a potent, orally active and ATP-competitive CFTR?inhibitor with an?IC50 of 4 nM.
-
GC69812
(R)-Elexacaftor
(R)-VX-445
(R)-Elexacaftor is the enantiomer of Elexacaftor (Compound 1) and comes from Compound 37 in patent WO2018107100A1. It is a corrector of cystic fibrosis transmembrane conductance regulator (CFTR), with an EC50 value of 0.29 uM for CFTR dF508.
-
GC67767
(R)-Olacaftor
(R)-VX-440
-
GC62513
(R)-Posenacaftor sodium
(R)-PTI-801 sodium
(R)-Posenacaftor (R)-PTI-801) sodium is the R enantiomer of Posenacaftor. -
GC70934
(R)-Vanzacaftor
(R)-Vanzacaftor ((R)-VX-121) is a regulator of cystic fibrosis transmembrane conduction regulator (CFTR).
-
GC72112
Astressin 2B TFA
Astressin 2B TFA is a potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist, with the IC50 values of 1.3 nM and > 500 nM for CRF2 and CRF1, respectively.
-
GC68723
Bamocaftor
VX-659
Bamocaftor (VX-659) is a cystic fibrosis transmembrane conductance regulator (CFTR) corrector designed to restore the function of F508del-CFTR protein. Bamocaftor can be used in combination with Tezacaftor and Ivacaftor for research on cystic fibrosis.
-
GC30537
BPO-27 racemate
BPO-27 racemate is a potent CFTR inhibitor with an IC50 of 8 nM.
-
GC63976
Cavosonstat
N91115
Cavosonstat (N91115) is an orally active S-nitrosoglutathione reductase (GSNOR) inhibitor. -
GC35667
CFTR corrector 1
VX-445
CFTR corrector 1 (VX-445, Compound 1) is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR). -
GC34532
CFTR corrector 2
CFTR corrector 2 is a cystic fibrosis transmembrane conductance corrector (CFTR), extracted from patent US20140274933.
-
GC67939
CFTR corrector 4
-
GC62510
CFTR corrector 6
CFTR corrector 6 is a potent potentiator of Cystic Fibrosis Transmembrane conductance Regulator (CFTR).
-
GC68282
CFTR corrector 8
-
GC65029
CFTR corrector 9
CFTR corrector 9 (compound 42) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator.
-
GC14421
CFTRinh-172
CFTR(inh)172, Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor 172
CFTR inhibitor, highly potent and selective -
GC67925
Crinecerfont hydrochloride
SSR-125543 hydrochloride; SSR-125543A
-
GC64121
Dirocaftor
-
GC68397
Galicaftor
ABBV-2222; GLPG-2222
-
GC19169
GLPG1837
ABBV-974
GLPG1837 is a potent and reversible CFTR potentiator, with EC50s of 3 nM and 339 nM for F508del and G551D CFTR, respectively. -
GC36149
GLPG2451
GLPG2451 is a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator, which effectively potentiates low temperature rescued F508del CFTR with an EC50 of 11.1 nM.
-
GC17804
GlyH-101
GlyH101, Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor II
CFTR Inhibitor II -
GC63353
Icenticaftor
Icenticaftor (QBW251) is an orally active CFTR channel potentiator, with EC50s of 79 nM and 497 nM for F508del and G551D CFTR, respectively.
-
GC11229
IOWH-032
CFTR inhibitor
-
GC10296
Ivacaftor (VX-770)
VX 770
Ivacaftor (VX-770) (VX-770) is a potent and orally bioavailable CFTR potentiator, targeting G551D-CFTR and F508del-CFTR with EC50s of 100 nM and 25 nM, respectively. -
GC12489
Ivacaftor benzenesulfonate
VX-770 benzenesulfonate;VX 770 benzenesulfonate;VX770 benzenesulfonate;Kalydeco benzenesulfonate
A CFTR potentiator -
GC13316
Ivacaftor hydrate
VX-770 hydrate;VX 770 hydrate;VX770 hydrate;Kalydeco hydrate
A CFTR potentiator -
GC70634
Ivacaftor-d4
Ivacaftor-d4 (VX-770-d4) is the deuterium labeled-Ivacaftor .
-
GC64678
K41498 TFA
K41498 TFA is a potent and highly selective CRF2?receptor antagonist with Ki?values of 0.66 nM, 0.62 nM and 425 nM for human CRF2α, CRF2β?and CRF1 receptors respectively.
-
GC14914
KM 11060
Corrects F508del-CFTR trafficking
-
GC63479
Navocaftor
GLPG 3067; ABBV-3067
Navocaftor (GLPG 3067), as a cystic fibrosis transmembrane regulator (CFTR), is a protein modulator (US 20200377491 Al, example 1). -
GC68015
NJH-2-057
-
GC64358
Olacaftor
VX-440
Olacaftor (VX-440) is a cystic fibrosis transmembrane conductance regulator (CFTR) modulator extracted from patent US9782408. -
GC10288
PG 01
CFTR mutants potentiator
-
GC62522
Posenacaftor sodium
PTI-801 sodium
Posenacaftor (PTI-801) sodium is a cystic fibrosis transmembrane regulator (CFTR) protein modulator that corrects the folding and trafficking of?CFTR?protein. -
GC17616
PPQ-102
CFTR Inhibitor IV, Cystic Fibrosis Transmembrane Conductance Regulator Inhibitor IV
potent CFTR inhibitor -
GC12346
PTC124(Ataluren)
PTC 124;PTC-124
PTC124(Ataluren) (PTC124) is an orally available CFTR-G542X nonsense allele inhibitor. -
GC34745
PTI-428
PTI-428
PTI-428 (PTI-428) is a specific cystic fibrosis transmembrane conductance regulator (CFTR) amplifier. -
GC67789
SRI-37240
-
GC69942
SRI-41315
SRI-41315 induces long pauses at termination codons, inhibits premature termination codons (PTCs) associated with permanent and primary human bronchial epithelial cell cystic fibrosis, restores the expression and function of CFTR (cystic fibrosis transmembrane conductance regulator). SRI-41315 inhibits PTCs by reducing the abundance of the termination factor eRF1. SRI-41315 also enhances aminoglycoside-mediated readthrough, resulting in synergistic increases in CFTR activity.
-
GC73522
Tezacaftor-d4
VX-661-d4
Tezacaftor-d4 (VX-661-d4) is the deuterium-labeled Tezacaftor , a F508del CFTR corrector. -
GC72897
UCCF-853
UCCF-853 is a CFTR modulator.
-
GC70933
Vanzacaftor
Vanzacaftor is a modulator of cystic fibrosis transmembrane conductance regulator (CFTR) for researching cystic fibrosis.
-
GC14920
VX-661
Tezacaftor
VX-661 (VX-661) is a second F508del CFTR corrector and help CFTR protein reach the cell surface. -
GC15455
VX-809
VX 809; VX809; Lumacaftor; VRT 826809
VX-809 (VX-809; VRT 826809) is a CFTR modulator that corrects the folding and trafficking of CFTR protein.